WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
This article is protected by copyright. All rights reserved.
Source: American Journal of Hematology - Category: Hematology Authors: Jason Brayer, Jeffrey E. Lancet, John Powers, Alan List, Lodovico Balducci, Rami Komrokji, Javier Pinilla‐Ibarz Tags: Research Article Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Hematology | Leukemia | Myelodysplastic Syndrome | Toxicology | Vaccines | Wilm's Tumor